Long-term Results of Adjuvant Imatinib Treatment for Localized Gastrointestinal Stromal Tumors after Surgery

OBJECTIVE: Despite the development of two significant classifications for recurrence risk evaluation among patients engaged with gastrointestinal stromal tumor and corresponding treatment criteria, recurrence happens in a number of the patients who were once classified as ineligible for treatment an...

Descripción completa

Detalles Bibliográficos
Autores principales: Aznab, Mozaffar, Akhmadi, Sayed Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844634/
https://www.ncbi.nlm.nih.gov/pubmed/29373890
http://dx.doi.org/10.22034/APJCP.2018.19.1.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844634/
https://www.ncbi.nlm.nih.gov/pubmed/29373890
http://dx.doi.org/10.22034/APJCP.2018.19.1.39

Ejemplares similares